Evidence map›Paper›PMID 42411344›Full record

ArticleAnnals of medicine2026

Prevalence and determinants of alcohol use disorder and its association with adherence to antihypertensive therapy among adult hypertensive patients in a hospital setting, Northwest Ethiopia.

Gizachew Kassahun Bizuneh

Abstract read
In one paragraph

Article in Annals of medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Gizachew Kassahun BizunehDepartment of Pharmacognosy, School of Pharmacy, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

methodsA hospital-based cross-sectional study was conducted among hypertensive outpatients at the University of Gondar Comprehensive and Specialized Hospital from January 30 to May 30, 2024. Participants were selected using simple random sampling. Alcohol use disorder was assessed using the Alcohol Use Disorders Identification Test (AUDIT) and medication adherence was evaluated over a three-month period. Bivariable and multivariable logistic regression analyses identifed factors associated with AUD and non-adherence to antihypertensive therapy. Statistical significance was set at

resultsA total of 400 participants were included (response rate: 100%), with a mean age of 44.9 ± 12.5 years. The prevalence of AUD was 12.2%, comprising hazardous drinking (8.0%), harmful use (2.5%), and alcohol dependence (1.7%). Male sex (AOR = 3.60; 95% CI: 1.30-9.94), cigarette smoking (AOR = 8.56; 95% CI: 3.89-18.82), and comorbidities (AOR = 3.87; 95% CI: 1.75-8.56) were independently associated with AUD. Overall, 42.2% of participants were non-adherent to antihypertensive therapy. Alcohol dependence was associated with nearly fourfold higher odds of poor adherence compared with social drinking.

conclusionAUD is common among hypertensive patients and is significantly associated with poor adherence to antihypertensive therapy. Integrating alcohol use screening and intervention into routine hypertension care may improve medication adherence and treatment outcomes.

Indexed as

AlcoholismAntihypertensive AgentsDrug MonitoringHypertensionMedication AdherenceAdultAlcohol DrinkingComorbidityCross-Sectional StudiesEthiopiaFemaleHumansMaleMiddle AgedPrevalenceRisk FactorsAntihypertensive AgentsAlcohol use disorderantihypertensive therapyEthiopiahypertensionmedication adherence

Identifiers

PMID42411344
PMCPMC13348112

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.